Janux Therapeutics

Janux Therapeutics

Biotechnology Research

San Diego, California 6,431 followers

About us

Janux is a clinical-stage company developing unique immunotherapies that have the potential to generate tumor-specific immune responses to attack and kill tumors without destroying a patient’s healthy tissue. Janux is using its platform masking technology to engineer novel drug candidates that are designed to overcome the traditional T cell engager toxicity and efficacy limitations. Janux is proud to have earned a 𝐆𝐫𝐞𝐚𝐭 𝐏𝐥𝐚𝐜𝐞 𝐓𝐨 𝐖𝐨𝐫𝐤 𝐂𝐞𝐫𝐭𝐢𝐟𝐢𝐜𝐚𝐭𝐢𝐨𝐧™ in 2024.

Industry
Biotechnology Research
Company size
51-200 employees
Headquarters
San Diego, California
Type
Public Company
Founded
2017
Specialties
Biotechnology

Locations

  • Primary

    10955 Vista Sorrento Pkwy

    Suite 200

    San Diego, California 92130, US

    Get directions

Employees at Janux Therapeutics

Updates

Similar pages

Browse jobs

Funding

Janux Therapeutics 5 total rounds

Last Round

Post IPO equity

US$ 296.5M

See more info on crunchbase